This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fidler, I. J. Articles by Budmen, M. B. Search for Related Content PubMed PubMed Citation Articles by Fidler, I. J. Articles by Budmen, M. B.

Tumoricidal Properties of Mouse Macrophages Activated with Mediators from Rat Lymphocytes Stimulated with Concanavalin A¹

Basic Research Program, National Cancer Institute, Frederick Cancer Research Center, Frederick, Maryland 21701

Macrophage-activating factor (MAF) was obtained from cultures of normal F344 rat lymphocytes incubated with insoluble concanavalin A. The MAF rendered macrophages from normal C57BL/6 mice cytotoxic against the syngeneic B16 melanoma and the allogeneic AC 15091. At the same time, normal syngeneic or allogeneic embryo cells were unharmed, even in the presence of susceptible tumor cells. Optimal MAF levels followed incubation of lymphocytes for 48 hr with Sepharose-bound concanavalin A. A 2-hr incubation of macrophages with MAF was sufficient to initiate activation, providing that 46 hr were allowed to elapse before tumor cells were added. The MAF activity was enhanced after heating the supernatant to 100°. Control experiments largely excluded the possibility that residual unbound concanavalin A caused the observed macrophagemediated tumoricidal effects.

¹ Research sponsored by the National Cancer Institute under Contract N01-CO-25423 with Litton Bionetics, Inc.

Received 4/ 9/76. Accepted 6/18/76.

This article has been cited by other articles:

				L. J. Dawson, S. E. Christmas, and P. M. Smith An investigation of interactions between the immune system and stimulus-secretion coupling in mouse submandibular acinar cells. A possible mechanism to account for reduced salivary flow rates associated with the onset of Sjogren's syndrome Rheumatology, November 1, 2000; 39(11): 1226 - 1233. [Abstract] [Full Text] [PDF]

				I. Fidler Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines Science, June 27, 1980; 208(4451): 1469 - 1471. [Abstract] [PDF]

				R. Schultz, N. Pavlidis, W. Stylos, and M. Chirigos Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series Science, October 20, 1978; 202(4365): 320 - 321. [Abstract] [PDF]